Anika Therapeutics | ANIK - Ebitda





Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Integra LifeSciences USD 78.41M 2.23M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sanofi EUR 3.69B 375M 2026-06
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.93B 357M 2026-06
Veracyte USD 43.96M 1.16M 2026-06
Xencor USD -34.63M 86.74M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06